Astera Labs (NASDAQ:ALAB) Shares Climb 13.7% – Here’s Why

Astera Labs, Inc. (NASDAQ:ALAB)’s stock price shot up 13.7% during mid-day trading on Monday. The stock traded as high as $220.08 and last traded at $216.87. Approximately 7,049,015 shares traded hands during trading, an increase of 37% from the average session volume of 5,161,966 shares. The stock had previously closed at $190.71.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera reported third-quarter revenue of about $585 million, ahead of expectations, and forecast fourth-quarter revenue of about $740 million at the midpoint. An analyst article also highlighted rising revenue per accelerator as customers adopt higher-value Scorpio switches, which could support continued growth and strong margins. Astera Labs Is Increasing Their Revenue Per Accelerator
• Neutral Sentiment: After falling 26% over five sessions despite strong results, ALAB was described as testing resistance in an oversold bounce. This may indicate a recovery attempt, though it does not yet confirm that the prior decline has ended. ALAB Price Prediction
• Negative Sentiment: Director Stefan Dyckerhoff disclosed sales of Astera Labs shares on November 5. The transactions were made under a pre-arranged Rule 10b5-1 plan, which makes them a less direct signal about the director’s outlook, but insider sales can still weigh on sentiment. SEC Form 4 filing
• Negative Sentiment: The recent sell-off despite strong earnings suggests investors remain concerned about ALAB’s valuation and shifting sentiment toward AI stocks. Strong data-center growth reported by larger chipmakers may validate demand, but also underscores competition for AI infrastructure spending. Astera Labs Stock Drops 26% in a Week

Wall Street Analysts Forecast Growth

Several analysts have weighed in on ALAB shares. Jefferies Financial Group raised their price target on Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Morgan Stanley boosted their price objective on Astera Labs from $382.00 to $389.00 and gave the stock an “overweight” rating in a report on Wednesday, November 4th. Susquehanna decreased their price objective on shares of Astera Labs from $310.00 to $258.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 4th. Northland Securities upgraded shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $315.00 target price for the company in a research report on Wednesday, November 4th. Finally, BMO Capital Markets assumed coverage on shares of Astera Labs in a report on Thursday. They issued an “outperform” rating and a $375.00 price target on the stock. Thirteen research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $320.85.

Astera Labs Trading Up 13.7%

The business has a fifty day moving average price of $300.46 and a 200-day moving average price of $255.80. The stock has a market capitalization of $37.90 billion, a PE ratio of 86.40 and a beta of 3.86.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, November 3rd. The company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.19 by $0.13. The company had revenue of $584.90 million for the quarter, compared to analysts’ expectations of $550.78 million. Astera Labs had a return on equity of 25.35% and a net margin of 29.64%. Astera Labs’s revenue for the quarter was up 153.6% compared to the same quarter last year. During the same period last year, the firm posted $0.49 EPS. On average, equities analysts anticipate that Astera Labs, Inc. will post 2.71 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Astera Labs news, COO Sanjay Gajendra sold 90,630 shares of the stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief operating officer owned 1,119,038 shares of the company’s stock, valued at $380,864,583.30. This represents a 7.49% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Philip Mazzara sold 6,801 shares of the firm’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the sale, the general counsel directly owned 96,542 shares in the company, valued at approximately $32,872,551. This trade represents a 6.58% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 408,558 shares of company stock valued at $126,050,884 over the last three months. 10.40% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Astera Labs

Institutional investors and hedge funds have recently bought and sold shares of the business. Harbour Investments Inc. grew its position in shares of Astera Labs by 15.9% in the 3rd quarter. Harbour Investments Inc. now owns 3,231 shares of the company’s stock worth $1,150,000 after buying an additional 444 shares during the last quarter. AlTi Global Inc. raised its holdings in shares of Astera Labs by 1.1% during the third quarter. AlTi Global Inc. now owns 5,977 shares of the company’s stock valued at $2,128,000 after acquiring an additional 67 shares in the last quarter. Danica Pension Livsforsikringsaktieselskab purchased a new stake in Astera Labs in the third quarter worth $794,000. Danske Bank A S lifted its stake in Astera Labs by 9.4% in the third quarter. Danske Bank A S now owns 75,605 shares of the company’s stock worth $26,913,000 after acquiring an additional 6,505 shares during the period. Finally, Drive Wealth Management LLC lifted its stake in Astera Labs by 68.8% in the third quarter. Drive Wealth Management LLC now owns 1,065 shares of the company’s stock worth $379,000 after acquiring an additional 434 shares during the period. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems.

The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

Founded in 2017 and headquartered in Santa Clara, California, Astera Labs serves the global cloud and computing markets.